Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials

Journal of Clinical Oncology

Volumn 24, Issue 3, 2006, Pages 419-430

  McCulloch, Michael ^b   See, Caylie ^b   Shu, Xiao Juan ^b   Broffman, Michael ^b   Kramer, Alan ^b   Fan, Wei Yu ^b   Gao, Jin ^b   Lieb, Whitney ^b   Shieh, Kane ^b   Colford Jr , John M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AI DI; ANTINEOPLASTIC AGENT; ASTRAGALUS EXTRACT; CAMPTOTHECIN; CARBOPLATIN; CHINESE DRUG; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; JIN FU KANG; MITOMYCIN; MITOMYCIN C; NAVELBINE; PACLITAXEL; PLATINUM COMPLEX; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE; HERBACEOUS AGENT;

ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; EMBASE; HUMAN; LUNG NON SMALL CELL CANCER; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ASTRAGALUS PLANT; CONTROLLED CLINICAL TRIAL; LUNG TUMOR; METHODOLOGY; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTRAGALUS PLANT; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUGS, CHINESE HERBAL; HUMANS; LUNG NEOPLASMS; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644846918     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.6392     Document Type: Article

References (61)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101:3-27, 2004
3. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy for non-small cell lung cancer [Cochrane Database System Review]. Oxford, United Kingdom, CD002139, issue 4, 2004
4. Rowell N, O'Rourke N. Concurrent chemoradiotherapy in non-small cell lung cancer [Cochrane Database System Review]. Oxford, United Kingdom, CD002140, issue 4, 2004
5. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer [Cochrane Database System Review]. Oxford, United Kingdom, CD002142, issue 4, 2004
6. Burdett S, Stewart L: Postoperative radiotherapy in non-small-cell lung cancer: Update of an individual patient data meta-analysis. Lung Cancer 47:81-83, 2005
7. D'Addario G, Pintilie M, Leighl NB, et al: Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A meta-analysis of the published literature. J Clin Oncol 23:2926-2936, 2005
8. Herbst RS, Giaccone G, Schiller JH, et al: Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2. J Clin Oncol 22:785-794, 2004
9. Mills S, Bone K: Principles and Practice of Phytotherapy. Edinburgh, Scotland: Churchill Livingstone; 2000
10. Wei H, Sun R, Xiao W, et al: Traditional Chinese medicine Astragalus reverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncol Rep 10:1507-1512, 2003
11. Pellegrini P, Berghella AM, Del Beato T, et al: Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 42:1-8, 1996
12. Zou YH, Liu XM: Effect of Astragalus injection combined with chemotherapy on quality of life in patients with advanced nonsmall cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 733-735, 2003
13. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement - Quality of reporting of meta-analyses. Lancet 354:1896-1900, 1999
14. Sutton AJ, Abrams KR, Jones DR, et al: Methods for Meta-Analysis in Medical Research. Chichester, United Kingdom, John Wiley & Sons, 2000
15. Petitti DB. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine (ed 2). New York, NY, Oxford University Press, 2000
16. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
17. Clark HD, Wells GA, Huet C, et al: Assessing the quality of randomized trials: Reliability of the Jadad scale. Control Clin Trials 20:448-452, 1999
18. Heritier SR, Gebski VJ, Keech AC: Inclusion of patients in clinical trial analysis: The intention-to-treat principle. Med J Aust 179:438-440, 2003
19. WHO. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland, World Health Orgnaization, 1979
20. Yates JW, Chalmer B, McKegney FP: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220-2224, 1980
21. Delbaldo C, Michiels S, Syz N: Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: A meta-analysis. JAMA 292:470-484, 2004
22. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
23. Cochran WG: The combination of estimates from different experiments. Biometrics 101-129 101-129, 1954
24. Whitehead A, Whitehead J: A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10:1665-1677, 1991
25. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101, 1994
26. Wang YQ: Integrated Chinese and Western medicine combined treatment for primary-stage lung cancer with pleural effusion. Liaoning Zhongyi Zazhi 27:129, 2000
27. Wang JX, Zhu CL: A clinical observation of the effect of supplementing Qi and nourishing yin prescription combined with MOP on the stage III IV of the nonsmall cell lung cancer. Shi Yong Zhong Xi Yi Jie He Za Zhi 10:1839-1840, 1997
28. Weng JY: Chinese and Western medicine in the treatment of 19 cases of advanced nonsmall cell lung cancer. Zhejiang Zhong Liu 4:129, 1998
29. Chen GP, Weng JY: Treatment value of Chinese medicine combined with chemotherapy for excision of lung cancer. Zhejiang Zhong Xi Yi Jie He Za Zhi 10:407-408, 2000
30. Sui DJ, Zhou LN, Li G: Fuzhengjian to treat middle to late-stage lung cancer in 40 patients. Shanxi Zhongyi 17:16-17, 2001
31. Liu JX, Shi ZM, Xu ZH, et al: Clinical observations of Jin Fu Kang Kou Fu Ye in treating non-small-cell lung cancer. Zhong Yi Za Zhi 38:727-729, 1997
32. Liu JX, Shi ZM, Li HG, et al: Clinical observations of lung nourishing anti-tumor beverage in treating non-small-cell lung cancer in 271 cases. Shanghai Zhong Yi Yao Za Zhi 2:4-6, 2001
33. Jin CJ, Li LN, Cui Q, et al: Clinical observation of chemotherapy and Chinese Medicine in treating advanced non-small-cell lung cancer. Shanghai Zhong Yi Yao Za Zhi 37:16-17, 2003
34. Yu LL, Han ZY: Clinical observation of Chinese herbal medicine combined with interventional chemoradiotherapy in the treatment of non-small-cell lung cancer. Zhongguo Zhongxiyi Jiehe Zazhi 23:56-57, 2003
35. Zhou HF: Chinese herbal medicine Yi Qi Yang Yin Tang combined with vinorelbine-cisplatin chemotherapy in the treatment of 46 patients with stage III and IV non-small-cell lung cancer. Zhejiang Zhongyi Zazhi 38:474, 2003
36. Liu SS: Clinical research of Fei Yi Liu He Ji in the treatment of primary bronchopulmonary cancer. Shan Dong Zhongyiyao Daxue Xuebue 28:99-102, 2004
37. Wang C, Wang LM, Xie GR: Clinical observation of Aidi injectable liquid simultaneously used with chemotherapy to treat non-small-cell lung cancer. Tianjin Zhongyi 19:61, 2002
38. Gao P: Clinical observation of Ai Di Zhu She Ye combined with chemotherapy in treating late stage non-small cell lung cancer. Henan Zhongyi 10:45-46, 2003
39. Lu J, Lu L, Fang J: Analysis of 75 patients with late stage non-small-cell lung cancer treated with Ai Di Zhu She Ye and chemotherapy. Shiyong Zhongyi Neike Zazhi 17:136, 2003
40. Zhang LH, Wang FZ, Liu GR: Observation of the effect of Chinese herbal medicine Ai Di Zhu She Ye combined with chemotherapy on short-term quality of life in late stage nonsmall cell lung cancer. Zhongguo Shiyong Neike Zazhi 23:427-428, 2003
41. Cheng WC, Ma L, Jin C, et al: Observation of the effects of Ai Di Zhu She Ye combined with Irinotecan protocol in the treatment of middle and late stage non-small-cell lung cancer. Zhongliu Yanjiu Yu Linchuang 15:199-200, 2003
42. Zhang NS, Yang DZ, Niu RG, et al: Analysis of 98 cases of middle and late stage non-small-cell lung cancer treated with Ai Di Zhu She Ye combined with chemotherapy. Zhongyiyao Xuekan 21:1599, 2003
43. Wang DJ, Chen YL, Ren J, et al: A randomized clinical study on the efficacy of Aidi injection combined with chemotherapy in the treatment of advanced nonsmall cell lung cancer. Zhongguo Feiai Zazhi 7:247-249, 2004
44. Gao CR, Xia HP, Shi JG, et al: Clinical observation of Shenqi pills combined with chemotherapy to treat non-small-cell lung cancer. Zhongguo Zhongxiyi Jiehe Zazhi 21:908, 2001
45. Sun SX, Wang XM, Yu RC: Analysis of Chinese medicine to benefit qi and tonify blood in the treatment of late-stage non-small-cell lung cancer. Zhongguo Zhongyiyao Xinxi Zazhi 9:57-58, 2002
46. Wang ZL: Clinical observation of Yi Qi Yang Yin Gu Ben Tang to reduce side effects of chemotherapy in patients with non-small-cell lung cancer. Jiangxi Zhongyiyao 33:40, 2002
47. Li DY, Ou CM, Li GD, et al: Clinical observations of Fu Zheng Pai Du Kang Ai Fang in increasing effectiveness and reducing toxicity of chemotherapy in non-small-cell lung cancer. Zhongguo Zhongxiyi Jiehe Zazhi 20:208-209, 2000
48. Chu GT, Cao YS, Zheng AP: 64 cases of non-small-cell lung cancer treated with Fu Zheng Qu Yu Tang combined with chemoradiotherapy. He Nan Zhongyiyao Xuekan 14:31-32, 1999
49. Liu Q: Observations of effectiveness of Yi Qi San Jie Fang combined with chemotherapy in treating 35 cases of middle and late state non-small-lung cancer. Shanxi Zhongyi 15:26-27, 1999
50. Fan YF, Xu QP, Jiang N, et al: Clinical study of tumor response with integrated Chinese Western medicine in the treatment of non-small-cell lung cancer. Fujian Zhongyiyao 34:6-7, 2003
51. Zhou H, Zhang DC: Zhang Shi Kang Ai San No. 5 combined with chemotherapy the treatment of late stage lung cancer. Hubei Zhongyi Zazhi 25:27-28, 2003
52. Fei CB, Wang YM, Wang LL, et al: Fu Zheng Chinese medicine combined with chemotherapy in the treatment of non-small-cell lung cancer. Liaoning Zhongyi Zazhi 30:266-267, 2003
53. Jia YJ, Shi FM, Jia CS, et al: Clinical research of Xiao Yan Tang in the treatment of late stage non-small-cell lung cancer. Tianjin Zhongyiyao 21:108-110, 2004
54. Cao Y, Yuan SH, Qiao ZB, et al: Clinical research on Yi Qi Yang Yin Fang combined with chemotherapy in the treatment of late stage nonsmall-cell lung cancer. Zhongguo Zhongyi Jichu Yixue Zazhi 9:32-33, 595, 2003
55. Li TS: Clinical study of Fei Bao Dan combined with chemotherapy in the treatment of advanced non-small-cell lung cancer. Zhongguo Zhongyiyao Xinxi Zazhi 6:50, 1999
56. Liu JX, Pan MQ, Li YH, et al: Clinical study of Jin Fu Kang oral liquid for treating non-small-cell lung cancer. Zhongliu 21:463-465, 2001
57. Zhang XH, Li J, Sun CY, et al: Clinical research on Ai Di Zhu She Ye combined with chemotherapy in the treatment of middle and late stage non-small-cell lung cancer. Zhonghua Zhongxiyi Zazhi 5:230-231, 2004
58. Moher D, Schulz KF, Altman DG: The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134:657-662, 2001
59. Hewitt C, Hahn S, Torgerson DJ, et al: Adequacy and reporting of allocation concealment: Review of recent trials published in four general medical journals. BMJ 330:1057-1058, 2005
60. Marwick C: Complementary, alternative therapies should face rigorous testing, IOM concludes. J Natl Cancer Inst 97:255-256, 2005
61. Yu GP, Gao SW: Quality of clinical trials of Chinese herbal drugs, a review of 314 published papers. Zhongguo Zhong Xi Yi Jie He Za Zhi 14 50-52, 1994